HOME / Notice / News / EN
NKCL Bio Group (Chairman Donghwa Shin), an advanced biopharmaceutical manufacturing company, announced on the 22nd that it had obtained permission for a cell processing facility based on the advanced regenerative bio method from the KFDA. NKCL Bio Group acquired permission to 'Manufacturing of Advanc...
As part of the policy pledge of the new government in 2022, in relation to fostering the advanced bioindustry, which is attracting attention as a growth engine industry, pharmaceutical and bio companies are announcing the latest biopharmaceutical manufacturing permits. This is interpreted as ‘legal ...
The prolonged COVID-19 has increased the importance of virus research worldwide. We have been affected by many viruses. Colds, which are now simply recognized, are also viruses. However, the perception of the virus is changing as we go through COVID-19, and the state's inability to play its role due ...
NKCL Bio Group Inc. announced on November 25 that it had won the Grand Prize in the ‘Innovation Sector’ award from the Minister of Small and Medium Venture Business. The Ministry of SMEs and Startups said, “NKCL Bio Group was highly evaluated for its contribution to the development of the Korean b...
NKCL Bio Group Inc. announced on the 25th that it had won awards in two categories, the Technology Innovation Division and the Innovation Division of the Ministry of SMEs and Startups, at the ‘9th 2022 TV Chosun Management Grand Awards’. It is an awards ceremony hosted by TV Chosun and sponsored by...